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FOREWORD
This paper is an attempt to review in the light of earlier research certain
recent work on measles virus with emphasis on the development of a living
attenuated vaccine against the disease. It was presented as a Cameron
Prize Lecture before the Faculty of Medicine, Edinburgh University,
16 May 1961. Since it has not been submitted for publication the author
decided it might be appropriate to offer it as his contribution to this col-
lection of papers that jointly testify to the great respect and affection which
all of his colleagues, pupils, and friends have for John Paul.
Although written for another occasion it seemed fitting for several
reasons to include it here. There is, among John Paul's earliest professional
communications, one devoted to a pathological study of measles con-
junctivitis. Throughout theyears as epidemiologist and distinguished student
of Preventive Medicine he has continued to maintain his interest in this
ubiquitous and fascinating disease. Recently in John Paul's laboratory
significant additions to our knowledge of measles have been made by sev-
eral members of his staff whose investigations he warmly encouraged.
Finally, as director and afterwards member of the Commission on Viral
Diseases of the Armed Forces Epidemiological Board he has, by his helpful
enthusiasm and wise counsel, contributed substantially to the studies in our
own laboratory which are described in this paper.
INTRODUCTION
The problem of vaccination against measles is an old one, and only
now may the solution be at hand. Its antiquity is accented by the fact that
the first attempt to immunize against measles preceded by nearly half a
century Jenner's discovery of smallpox vaccine. This first attempt was
made in 1758 by Francis Home of Edinburgh. Home was then a Fellow
of the Royal College of Physicians and, to judge by his many excellent
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case reports, an active practitioner in the City and in the Infirmary. Later
he became Regius Physician and Professor of Materia Medica in the
University.
In reading Home's prototypic experiments as well as some of his other
medical writing. I have been impressed with the keenness of his powers of
observation, the logic and modernity of his thinking, his experimental
approach to clinical problems, and his healthy scepticism. These character-
istics reveal the father of inoculation against measles as a somewhat neglected
forerunner of the great age of experimental medicine that was to come
in the next century.
Measles in Home's time appears to have presented a far more serious
problem than it does nowadays, at least in the so-called "well developed"
countries. In other parts of the world, however, as I shall later reemphasize
it still frequently takes the form of severe illness with a mortality that is
far from negligible. The gravity of the disease in mid-eighteenth century
Scotland is well exemplified by Home's statement at the beginning of his
book entitled "Medical Facts and Experiments" in which he described
his work on vaccination. Here he remarks, in what to us today appears to
be a monstrous understatement, that in the epidemic which occurred in
Edinburgh about the beginning of December, 1758 the measles were "in
general of a mild sort; and not about the twelfth part died of those who
were attacked". Further on he implies that in former outbreaks the in-
cidence of serious complications, especially that of pneumonia, as well
as the mortality was much higher.
This disturbing situation led him to attempt inoculation of "morbilous
matter" by a parenteral route in the hope, as he puts it, of rendering "the
disease more mild and safe in the same way as the Turks have taught us
to mitigate the smallpox". Home's theoretical basis for this procedure
appears eminently logical. "I suspected strongly", he wrote, "that the
cough, often so harassing, even in the mildest kind, was produced by re-
ceiving the infection mostly by the lungs; and I hoped that this symptom
would abate considerably if I could find a method of communicating the
infection by the skin alone".
At the outset Home was confronted with a major difficulty; for, unlike
smallpox there was, as he says, "no matter to be had from the measles"
that appeared suitable for inoculation. He goes on: "A woolen glove taken
from the arm of a measly patient would not answer my purpose, as part
of the infection might be drawn in by the lungs. I could not find a sufficient
quantity of scaly matter, after the measles were dried, to serve my purpose".
Characteristic of his intuitive correctness of thought was the way he
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"'er leapt" this hurdle: "I then", he declares, "applied directly to the
magazine of all epidemic diseases, the blood". Not only in the choice of blood
as inoculum but also in that of the optimal time for taking it he displayed
much discernment: "As the measly matter behoved to be but a small
proportion of the whole mass, I chused to make use of the blood when it
contained the morbilic matter in the highest state of acrimony". He reasoned
that the time of the "highest state of acrimony" or, as we should say,
virulence, was at the peak of the fever, shortly after the eruption appeared.
Experiments of the present century have justified Home's choice since
they showed not only that viremia regularly occurs but that the virus
present in the blood at the onset of the eruption soon thereafter disappears
from the circulation. Noteworthy also are his conjectures that the amount
of the virus in the blood is small and, as he points out later, may rapidly
lose its infectivity if the blood is too long preserved before inoculation.
These enlightened guesses have lately received ample experimental con-
firmation by investigators such as Ruckle and Rogers and ourselves, using
the tissue culture method which I shall soon mention.
Home described the results of inoculation of measles blood in a group
of twelve children. In ten of them an eruption that he considered charac-
teristic of the disease was noted following a rather regular interval. Two
of the oldest children, one of whom gave a history of measles, failed to
present an exanthem. Rash, when it occurred, was usually preceded by
fever, signs of conjunctivitis and coughing. These manifestations ap-
peared most frequently six to seven days after inoculation and usually
preceded the rash by one to three days. That he "might see the difference
of the disease when it is communicated by the lungs alone and when by the
skin alone" Home inoculated three other children with blood or nasal
discharges from measles patients. None of these three subsequently came
down with the disease.
A number of subsequent workers failed to confirm his observations with
measles blood while a few reported success. Prophylactic inoculation was
never exploited on a large scale presumably because of these negative
trials and because of the difficulty of obtaining material for inoculation
at a convenient time. Difficulty of preserving the infectivity of the inoculum
also probably spoke against its adoption. Finally Hektoen, in 1905, in a
detailed and critical review of Home's results, seemed to give the coup de
grace to the claim that he had achieved the experimental transmission of
measles.
Hektoen sweepingly concluded that probably not one of Home's cases
developed measles as a result of inoculation because the incubation period
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fell short of that in the natural disease, being in no case longer than 10
days, and because Home's failed to exclude the possibility of natural
exposure prior to inoculation. The force of Hektoen's objection that the
incubation period was too short to be compatible with measles is, I
believe, largely dissipated by our own observations which I shall subse-
quently present, observations on the accelerated development of signs
of modified measles following administration of an attenuated measles
virus. Hektoen's second objection cannot be so readily met since it must
be admitted that chance exposure of some of the subjects may have oc-
curred. Indeed, Home himself was quite aware of this possibility. But
as he takes pains to point out, there were at least in two instances in
which inoculations were made at the end of August when there were no
cases of natural measles in the community. Furthermore, it would seem
unlikely that so large a proportion of the children would have developed
measles after approximately the same interval following inoculation had
previous exposure been responsible.
I suggest, therefore, that the laurels, of which Home seems to have
been unjustly denied, should be, in the light of recent findings, restored
to this pioneer in the experimental study of measles. In any event, recent
investigations which I shall summarize will serve to show that his basic
ideas concerning prophylaxis in this disease still live on.
THE VIRUS OF MEASLES
Historical. Any attempt to develop a safe and effective vaccine against
an infectious disease must be preceded by identification of the etiologic
agent, its isolation in a pure condition or in a state free of other pathogenic
microorganisms, its reproduction in sufficient quantities, and its preservation
in an antigenically stable form. To those must be added objective tests for
resistance of susceptibility and methods for assay of antigenic potency
of the vaccine. Home's attempt to inoculate against measles proved abortive
because in his time none of these technical requirements could be ade-
quately met. Indeed in the case of measles virus it is only within the past
seven years that reliable and effective procedures for meeting them have
been developed.
This tardiness is not attributable to lack of effort, since during the
preceding fifty years of this century numerous investigators sought to
discover susceptible animal hosts, and to propagate the virus in tissue
cultures or in the developing chick embryo. The results of these numerous
investigations were relatively meager, but certain valuable contributions
were made. Indian monkeys inoculated with materials from measles patients
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were found by Goldberger and Anderson to develop a mild form of the
disease. This observation was confirmed, although certain investigators
noted that frequently individual monkeys failed to develop overt signs
of infection. This variation in susceptibility rendered the experimental use
of these animals difficult or unsatisfactory. Numerous accounts of successful
inoculation of other species, such as guinea pigs, rabbits and mice, ap-
peared from time to time but none received general confirmation. Similarly
several authors described the propagation of the virus in chick embryos
and in chick cell tissue cultures. But again consistent confirmation was
lacking. Perhaps the most notable of these studies in which chick embryos
were used are those of Rake, Shaffer and Stokes, who in about 1940
inoculated monkeys and a large group of children with materials from
serial egg passages that were initiated with infected blood or throat wash-
ings from measles patients. Signs of modified disease were observed in a
small proportion of the children, but on subsequent exposure to measles
little or no protection was afforded and the investigations were not ex-
tended. Rake and his co-workers were handicapped by the variable re-
sponse of the monkey, and lack of any means for the detection and measure-
ment of specific measles antibody whereby they might determine the
antigenic potency of the vaccine or distinguish between susceptible and re-
sistant animals or human beings.
Because of these many equivocal results it became increasingly ap-
parent that to achieve further progress two things were needed: first, a
simple culture system which would be affected by the virus in such a
way as to make it easily apparent that viral multiplication had occurred
within the system itself; second, experimental animals of uniform sus-
ceptibility to the virus. Given these two essential tools, one felt con-
fident that reliable techniques could be readily developed for isolating
the virus, studying changes in its virulence, and producing it in quantity.
Procedures would also be provided for the detection and assay of anti-
bodies and for determining the potency of any vaccines that might be
developed.
Isolation in Tissue Culture. It seemed that the tissue culture techniques
which Weller, Robbins, and I had successfully used in the propagation of
the polioviruses might at least provide us with one of these tools. Ac-
cordingly, in 1954, with Dr. Thomas Peebles, blood and throat washings
taken in the early exanthematous phase from typical cases of measles were
added to roller tube cultures of normal human kidney tissue. After a
considerably longer incubation period than is characteristic of poliovirus
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we saw changes in the new outgrowth of renal epithelial cells which were
quite unfamiliar and therefore exciting.
These changes occurred focally and consisted of loss of cell bound-
aries with consequent mingling of cytoplasm to form an extensive mass
in which numerous nuclei lay embedded. When stained, affected areas
closely resembled syncytia or multi-nucleated giant cells. In nearly every
nucleus within the syncytium large, intensely staining eosinophilic in-
clusion bodies were seen, surrounded by a clear halo. In the syncytial
cytoplasm eosinophilic bodies of irregular size and shape were frequent,
but not invariable, features. These cytopathic effects proved to be repro-
ducible in series when the fluid from an infected culture was trans-
ferred to a fresh preparation. The concentration in the culture fluid
of the transmissible agent thus revealed could now be easily determined
by testing increasing dilutions of the fluid for their capacity to induce
these changes. Filtration through bacteria-retaining membranes and failure
to demonstrate bacteria in infected fluids served to provide definite
evidence for the viral nature of the agent we had cultivated. These obser-
vations have been repeatedly confirmed by other workers.
Serological Identification. Evidence strongly suggesting that this agent
was in fact the virus of measles was obtained by showing that the distinctive
cytopathic changes failed to appear when the serum from patients con-
valescent from measles was mixed with the virus-containing tissue culture
fluid and introduced into fresh cultures. In contrast sera taken in the early
acute phase exhibited no such suppressive or neutralizing effect. The virus-
neutralizing effect of convalescent phase sera was thus shown to depend on
a specific antibody that develops during the course of measles. Furthermore,
we found that fluids from infected cultures contained an antigen which
fixed complement with convalescent but not with acute phase measles serum.
Very recently Chany in France and Rosen in the United States have shown
that measles virus hemagglutinates rhesus monkey red cells and that this
hemagglutination is specifically inhibited by convalescent measles serum.
Effect of Virus on Monkeys. Additional assurance that we were dealing
with the virus of measles was obtained when we inoculated fluids from
infected cultures into susceptible monkeys. Before these inoculations were
done, since we now had the techniques available, and since we had in
mind the irregular response of these animals noted by earlier workers, we
tested the sera of rhesus and cynomolgous monkeys for the presence of
measles antibodies. The animals first selected had been held for consid-
erable periods of time in three different laboratories. Virus neutralizing
and complement fixing antibodies were found in all eight of the cynomolgous
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and in thirteen of sixteen of the rhesus monkeys tested. Frequently the
concentration of antibody was high. When a few of these monkeys were
inoculated with the tissue culture virus they failed to present any signs of
infection. Here apparently we had a satisfactory explanation for the varia-
tion in susceptibility of individual monkeys.
To explain these observations it occurred to us that animals with
antibodies might have become infected with measles virus or a closely
related agent following their capture and confinement in the laboratory.
To test this hypothesis we procured, with the assistance of the United
States Armed Forces, a number of cynomolgous monkeys that had just pre-
viously been captured in the Philippines. No measles antibodies were de-
tected among the first ten animals examined. Subsequently we tested
approximately fifty additional cynomolgous monkeys that were shipped to
us promptly after capture in the Philippines or Malaya and found them
to be quite free of antibody. Comparable results have now been obtained
by several other workers.
When monkeys exhibiting negative complement fixation or neutralization
tests were inoculated with culture fluids containing the agent one or
more manifestations of infection became apparent. These consisted of
viremia discernible about the 4th or 5th day which persisted for several
days thereafter; moderate leucopenia lasting from about the 7th to the
11th day and a macular measles-like rash on face, trunk, and abdomen.
In all animals antibodies specific for the virus began to appear in the
blood about the 15th day. Of the various signs, viremia and the emergence
of antibody proved to be the most constant and reliable.
Taken as a whole these observations provided the basis for reinvesti-
gation of various aspects of the disease and its causative agent including
the problem of specific prophylaxis.
Other Relevant Properties. i) Antigenicity. Since these tools became
available a great deal has been learned through the efforts of a number
of investigators in Europe, Japan, and America about the nature and
properties of measles virus. As background for the studies on vaccination
to be reviewed, I shall summarize rapidly a relevant portion of this new
information.
Perhaps most important is the demonstration of the high antigenic
potency of the virus when it is introduced into the body in an infective
state. Serological analyses carried out with the new techniques by Black
have demonstrated the presence of neutralizing and complement fixing
antibodies in the serum of over 90 per cent of older persons in an urban
population in Connecticut. Titers of these antibodies ranged from about
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1:16 to 1:64 or higher in more than one half of Black's subjects. These
concentrations are not greatly inferior to those attained soon after an
attack of measles. The antigenic efficiency of live virus is also emphasized
by the rapid mobilization of antibody following infection. Bech, for ex-
ample, in a recent analysis of a large number of sera from cases in a
measles outbreak that occurred in Greenland detected antibodies in a
significant proportion as early as 48 hours after onset of rash and in
all sera examined within 5 days thereafter. In a subsequent study
Bech found that in 90 per cent of persons examined little change in
antibody concentration occurred between the 1st and 5th years after an
attack.
These observations testifying to the solid, lasting immunity resulting
from natural infection encourage the belief that a vaccine composed
of an attenuated live virus might likewise induce a satisfactory state of
resistance.
Concerning the antigenicity of measles virus after inactivation by
heat or chemicals there are so far few published data. However, these
are sufficient to indicate that after inactivation by formaldehyde, or by
gentle heating, antigenicity may be retained despite repeated injections
of the inactivated material which are required to achieve antibody levels
approaching those established by infection. Very little is known as yet
about the persistence of antibody after immunization with inactivated
virus or about its capacity to protect upon exposure to measles.
ii) Antigenic Homogeneity. Fortunately for those contemplating vaccination
against this disease, it now appears that all strains of the virus are
probably antigenically homogeneous. No differences in specificity have
been distinguished between viruses isolated in England, Denmark, Japan,
and the United States. Moreover, several strains recovered in successive
years from cases in the area of Boston, Massachusetts have, in our hands,
proved indistinguishable in respect to antigenic composition. It is, of
course, possible that strains may be discovered that are not antigenically
homogeneous with those known at present. To me, however, the exist-
ence of such heterologous strains is unlikely, since one would expect
the incidence of second attacks of measles would be higher if different
antigenic types existed in nature. This reasoning is supported by the
situation in the case of mumps where second attacks are also a rarity
and where over a period of twenty years no significant antigenic dif-
ferences have been noted between the numerous strains of virus that have
been studied.
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iii) Capacity to Multiply in Cells of Various Species and Types. It has
been shown in many recent experiments that measles virus, once it has
been isolated and grown for a number of generations in human or monkey
cell cultures, can be adapted more or less readily to other cell systems
such as bovine kidney cells and a variety of continuous or laboratory-
maintained lines of human and monkey cells. The Edmonston strain has
also been adapted to chick embryo cells. Adaptation to chick cells is of
much significance for the problem of vaccination and I shall refer to
it again in more detail. Certain of these systems offer advantages
over others for particular purposes. Because of the known malignant
character of some and the possible malignant character of others it has
not been proposed to use any of the available continuous cell lines for
propagation of virus to be used in the preparation of vaccines. For this
purpose only chick embryo, primary human amnion, and canine renal
cell cultures have so far been given serious consideration.
iv) Stability. In relation to vaccination with an attenuated virus such as
we have developed, the stability of the agent on storage under various
conditions is obviously of much practical importance. It has been determined
that in complex fluid media such as are used to nourish tissue cultures
measles virus rapidly loses its infectivity at 37°C. Happily, at icebox
temperatures activity is preserved for several weeks and, as we found in
our laboratory, at the temperature provided by solid C02, it may be pre-
served at least for four years. It has also been demonstrated in the laborator-
ies of several pharmaceutical manufacturers in the United States that when
suspended in a suitable chemical milieu the virus can be dried from the
frozen state with only moderate loss of infectivity. When once frozen
and dried, it may be kept in the icebox for many months with little or
no decrease in activity. Thus the stability of the measles virus, although
far less than that of certain others such as poliovirus, is, under ap-
propriate conditions, sufficient to permit manufacture and distribution of
an attenuated virus vaccine.
v) Yield of Virus in Tissue Culture. In the future if immunization against
measles should be practiced as routine, large quantities of vaccine would
be required. Therefore, the characteristics of the growth of measles virus
in various cell systems also becomes a matter of practical interest. As I
have already remarked, this agent grows at a slower rate in comparison
with certain other viruses. In unpublished experiments done several years
ago employing human renal cell cultures, we found little evidence of virus
multiplication as judged by assay of the nutrient fluid until about
the 6th day. Maximum yields were not obtained until about the 9th day.
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In chick cell cultures multiplication of the attenuated variant that we have
tested as vaccine follows an essentially similar pattern.
The concentration of virus attained in the fluid phase does not usually
exceed 100,000 tissue culture infective doses per ml. The quantity of
virus within the cells is about 10 times greater. Once viral reproduction
has reached a maximum it remains at a steady rate for days or even
weeks in primary cell cultures. At this maximum the rate of reproduction
is exceedingly rapid as determined by Black and by ourselves in unpublished
experiments. This fact gives ample assurance that measles virus can be
easily and economically produced in large quantities, since successive
harvests of infected fluids can be made from a single set of cultures.
vi) CrossReactionswith CDVandRinderpest Viruses. My final remarks on
the properties of measles virus concern the evidence for antigenic rela-
tionships between this agent and two viruses causing disease in lower
animals, namely canine distemper and rinderpest virus. As long ago as
1928 Bryan postulated, on the ground of pathological and clinical similar-
ities, a relationship between the agents of measles and distemper. Pinkerton
and Adams in the United States subsequently embraced this hypothesis and
supported it with additional data of the same sort. Karzon in 1955 showed
that a large proportion of adolescents have neutralizing antibodies for
canine distemper virus. The possibility was then raised that these anti-
bodies develop as a result of infection with measles virus. Subsequently
several workers have noted an increase in distemper antibodies following
infection with measles virus. In contrast, it has proved impossible to
demonstrate in human subjects an increase in antibodies to measles virus
following the inoculation of the distemper agent.
Contemporaneously with this work on antigenic crossing between measles
and distemper viruses in the United States, Polding and his associates
in East Africa discovered that canine distemper and rinderpest viruses
were also related. Later Plowright, also in East Africa, revealed a
relationship between the rinderpest and measles virus when he found
that in children, following an attack of measles, antibodies reacting with
rinderpest virus developed in a high proportion of cases.
From the practical standpoint these biologically interesting relation-
ships have stimulated investigation of the possibility of using distemper
virus as an immunizing agent against measles. Adams in 1959 reported
that the attack rate in an institutional population previously given live
distemper virus vaccine was somewhat lower than it was in unvaccinated
control groups. Hoenkenga and his associates in a trial carried out in
Central America observed a slight reduction in the incidence of measles
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in subjects who had received attenuated distemper virus vaccine but
concluded that the potency of the distemper virus vaccine was too low to
be useful. The use of canine distemper virus as a prophylactic against
measles, therefore, does not at the moment appear promising. Further
investigation, however, will be necessary before its consideration can be
finally disregarded.
VACCINATION AGAINST MEASLES
Attenua.tion of the Virus. The newer knowledge of the measles virus, as
I previously remarked, has been presented essentially by way of background
for the trials of the attenuated virus vaccine in man which I shall now con-
sider. These trials were carried out by us in collaboration with a number of
investigators, or by others working independently with vaccines prepared
in this laboratory from a virus attenuated in its virulence for monkeys.
This virus represents the distant progeny of a strain isolated from
the blood of a patient and designated the "Edmonston" strain. When first
recovered in human renal cell cultures, it failed to multiply in chick
embryos but produced all the signs of measles in monkeys that I have
described. After 24 passages in human renal cells followed by 28 passages
in human amnion cell cultures, Milovanovic of Yugoslavia, who was
then working in our laboratory, showed that the Edmonston strain had
gained the capacity to grow in the developing hen's egg. After 6 serial
passages in the egg, Katz and his associates found, as might be expected,
that this agent could be easily propagated in cultures of trypsinized
chick embryo cells. During the first four passages in this system the
virus exhibited no recognizable cytopathogenic properties, but subse-
quently caused cell-rounding, formation of small giant cells, and a
peculiar morphological transfiguration that we called "spindle cell" for-
mation. This latest effect had been noted early in human amnion cell
passages and consists of an elongation of the typical epithelial cell into
a shape reminiscent of the fibroblast.
When this chick cell-adapted virus was inoculated by the combined
nasal and intravenous routes into susceptible monkeys no overt signs of
infection were noted with the exception of a slight leucopenia. In system-
atic attempts to recover virus from the throat and blood of the inoculated
animals none was demonstrated except in one monkey in which virus
was detected in a single blood specimen. Obviously the reactions of the
monkey to this chick adapted virus were in marked contrast to those
induced by the agent when first isolated in human kidney cells. In spite
of this absence of signs of infection, all monkeys that received it de-
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veloped, by the 21st day, complement fixing and neutralizing antibodies
in concentrations comparable to animals given the virus in its original
virulent form. When challenged with virulent virus all of the vaccinated
animals proved resistant as indicated by failure to exhibit any clinical
signs of infection or demonstrable virus in the blood. These results indicated
clearly that at some time during its prolonged sojourn in vitro, its virulence
for the monkey had markedly decreased while the antigenic capacity was
fully retained.
A pronounced difference between the capacity of the chick-adapted
variant and its progenitor to persist and multiply in the central nervous
system of the monkey was also demonstrated. In comparative experiments
monkeys were inoculated with one or the other of these viruses into the
hypothalamic region and into the cisterna magna. Thereafter specimens
of spinal fluid, blood and throat swabbings were collected at frequent
intervals and examined for the presence of the respective agent. Tests
for antibodies were made at appropriate times. In the animals that re-
ceived chick cell-adapted virus the agent failed to appear in the spinal
fluid, nor was it demonstrated at any time in throat swabbings or blood.
In contrast the parent virus was repeatedly recovered from the spinal
fluid as well as other materials examined. It is particularly to be noted
that antibody responses were comparable in both animals. Histological
examination of sections of cord and brain taken 21 days after inoculation
revealed no lesions attributable to either the virulent or attenuated agent.
First Trial of Vaccine. Because of its loss of pathogenicity for monkeys
with retention of immunogenic properties we decided to explore the pos-
sibility of using in man the attenuated virus as a vaccine. We were re-
assured by these findings indicating that the capacity of the attenuated
agent to multiply in the central nervous system of the monkey was clearly
less than that of the virulent parent strain, since it would be a priori
less likely to cause encephalitis in human beings.
Accordingly, we proceeded to prepare with the attenuated agent a
vaccine to be used in an initial small trial in susceptible children. Attenuated
virus in the 14th chick cell passage was grown in chick cell cultures
nourished with the protein-free medium #199 of Morgan and Parker.
To infected fluid taken from cultures during the period of maximal virus
production a small amount of purified human serum albumin was added to
stabilize viral infectivity. This material represented the vaccine which was
preserved until use in the frozen state. After performance of the usual
tests for bacterial contamination and animal toxicity, my associate, Dr.
Samuel L. Katz, in October of 1958 administered the vaccine, with the
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consent of parents or guardians, to 11 mentally defective institutionalized
children who were regarded as susceptible to measles. Criteria for suscep-
tibility consisted of negative history for measles and negative tests for
neutralizing and complement fixing antibodies. Approximately 60 tissue
culture infecting doses of virus were injected into each child by the
subcutaneous route. As controls two susceptible children, who continued
to remain intimately associated with the vaccinated group, were at the same
time given sterile tissue culture fluid.
The clinical and serological events that followed in the vaccinated chil-
dren may be summarized. No immediate reactions either at the site of
inoculation or of a generalized sort were noted. After six - nine days,
a rise in rectal temperature was recorded in eight of the vaccinated chil-
dren which lasted from 2 to 5 days with a mean duration of 3.5 days.
Maximal temperature recordings ranged from 100.8 to 103.8 F. with a
mean of 102.8 F. After defervescence a pink, macular, nonpruritic, discrete
rash af varying extent appeared in nine children. In five of them it might
easily have escaped superficial examination. Koplik spots were seen in
one child with a questionable rash. The rash appeared usually about the
11th day and lasted from 1 to 3 days. In four children it was seen only
about the face and neck, in four others in addition to these areas the
trunk was involved. In general the picture and of a mild, much modified
measles. The most striking feature was the absence of any sign of dis-
ability. Notable, too, was the absence of any signs of involvement of the
respiratory tract. In every case the child went about his usual routine
with no loss of appetite or impairment of excretory functions. Two of the
vaccinated children and the two control children exhibited no clinical signs
of infection. Specimens of blood and throat washings obtained from each
of the thirteen children on the 5th, 9th, and 15th day after vaccination
were tested in tissue cultures for the presence of measles virus. None
was demonstrated.
By testing specimens of serum taken from each child at appropriate
intervals, emergence and decline of complement fixing and neutralizing
antibodies were followed. Antibodies developed in all of the vaccinated
children. Complement fixing antibodies were first detected on the 15th
post vaccination day and attained the highest concentration recorded on
the 22nd day. At themaximum, serum dilution titers ranged from 32 -256.
This range, as I shall again emphasize, approaches that exhibited by most
individuals convalescent from natural measles. On the 36th day titers
of neutralizing antibodies ranged from 90 - 300, again a range com-
parable to that most often encountered in early convalescence. At intervals
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during the 2X2 years elapsing since vaccination antibody levels have been
determined. A curve of the geometric mean titers at these intervals is
shown in Figure 1. It will be seen that from the maximum neutralizing
antibodies declined by about a factor of 4 by the end of one year. Since
that time, however, the level has remained essentially unchanged. The
initial decline in complement fixing antibody was more pronounced and
the titers finally attained were lower.
PERSISTENCE OF ANTIBODIES AFTER VACCINATION
GEOMETRIC MEAN OF II CHLDREN
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FIG. 1.
During this observation period of 2X2 years, cases of natural measles
have not occurred in the institution. We may confidently assume, there-
fore, that the vaccinated children have not been exposed. This assumption
is also supported by the fact that tests for measles antibodies in the
sera of the two control children have been consistently negative. Accord-
ingly, the appearance and persistence of antibodies may be attributed to
the effect of thevaccine.
From the results of this first small trial it was also concluded that:
i) The virus employed as vaccine is to be identified as the agent of
measles.
ii) Under the conditions to which it was subjected in the laboratory,
its virulence for man as well as for the monkey was reduced, but
to a less degree.
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iii) The virus is not transmitted from vaccinated subjects to susceptible
contacts.
Additional Studies of the Original Vaccine. Because of the elevated
temperatures noted in a few of the children in this first group an attempt
was made to induce further attenuation of the virus. Accordingly, the
vaccine strain was subjected to six additional chick embryo and four chick
cell passages. A vaccine was prepared with virus from the last passage
and, to distinguish it from the original vaccine or Vaccine A, it was re-
ferred to as Vaccine B. When Vaccine B was tested in susceptible children
by Lepow and her associates in Cleveland, Ohio, they obtained the same
spectrum of reactions which we had observed with Vaccine A.
Approximately 470 children and adolescents have now received paren-
terally either vaccine A or B. Since no difference in the effects of these
vaccines was noted, we have assumed that all these subjects received
comparable inocula. This large group of 470 children was made up of
a number of small groups consisting of patients in institutions for the
mentally retarded, patients attending a neurological clinic, patients with
cystic fibrosis of the pancreas, and normal children in institutional schools
and in the home. A number of investigators collaborated in these studies
and have published or will soon publish their observations. We are greatly
indebted to them for their interest and skillful management of these
trials.
The relevant serological and clinical findings in the first 272 children
in the series may be summarized as follows. To be first noted is the
fact that many of the children did not respond to vaccination by the de-
velopment of antibodies. Failure to respond was correlated in 101 of
107 cases with the presence of measles antibody in the pre-vaccination
serum specimen suggesting that most of these non-reactors had previously
experienced an infection. Of the 171 children in whose pre-vaccination
sera no antibody was demonstrated, 165 or 96.5 per cent developed anti-
bodies in significant concentrations following vaccination. We cannot
clearly account for the failure of six initially negative reactors to respond.
Possibly the quantity of virus in the inoculum was insufficient, but, more
probably, pre-existing undetected low levels of antibody were responsible.
However this may be, it was evident that the incidence of serological
response to vaccination among the susceptibles was gratifyingly high.
As shown in the examples listed in Table 1, antibody concentrations
attained after vaccination, approached those characteristic of convalescent
phase sera from measles patients. The differences observed between the
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mean antibody titers of the various groups probably depend in large part
on technical factors.
The principal clinical reactions to vaccination among the children with
initial negative serologic tests consisted of fever and exanthem. Fever
usually began on the 7th or 8th day and lasted on the average about
3 days. The average maximal temperature by rectum was 102.40F. The
upper limit of 1060F. occurred in a single child who exhibited no other
signs of illness and whose temperature quickly dropped after aspirin
TABLE 1. COMPARISON GEOMETRIC MEAN TITERS OF ANTIBODY AFTER
NATURAL MEASLES AND MEASLES VACCINATION
No. Geo. Mlf.
Author Subjects Stimulus sera Tit.* Range Tit.*
Bech' Normal Natural Measles 72 195 32-1024
Haggerty9 Normal Vaccine A 32 121 16-256
Katz and Enders9 Mentally Retarded Vaccine A 11 70 32-256
Black9 Mentally Retarded Vaccine A 9 75 16-256
Krugman9 Mentally Retarded Vaccine B 17 206 64-1024
* Reciprocal serum dilution end-point.
was given. In twenty-three or 14%o of 165 children who developed anti-
bodies no significant febrile response was recorded.
Only about one-half of the subjects developed a rash - definitely fewer
than in our initial small trial. Again I would stress the fact that the
rash usually appeared on the 10th to the 11th day when the temperature
in most cases had returned to normal. Thus the interval between inocula-
tion and appearance of rash corresponded with that noted by Francis Home.
In appearance and distribution the rash was reminiscent of that asso-
ciated with measles modified by gamma globulin. Koplik spots were
seen only in a small proportion of the children. With very few exceptions
the absence of disability was remarkable.
The results in two other groups who have received vaccine of the
same manufacture deserve special comment. One consisted of children with
cystic fibrosis who attended the clinic of Dr. Harry Schwachman at the
Children's Hospital Medical Center, Boston, Massachusetts; the other of
children suffering from a variety of neurological and metabolic disorders
who attended the clinic of Dr. Frederic Gibbs and Dr. Ira Rosenthal of
the Department of Pediatrics, University of Illinois College of Medicine,
Chicago, Illinois.
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The children with cystic fibrosis were chosen for vaccination because
in such patients natural measles is often followed by serious disease of
the lower respiratory tract which is frequently the seat of prior in-
fection by bacteria or fungi. In Dr. Shwachman's clinic, as elsewhere in
the United States, it is the practice in these patients to administer gamma
globulin as a prophylactic measure after each exposure or presumptive
exposure to measles, a troublesome and not always reliable procedure.
TABLE 2. CLINICAL REACTIONS AFTER MEASLES VACCINATION IN
125 PATIENTS WITH CYsnc FIBROSIS
No. of patients and incidence
Uncorrected Corrected
Reaction No. N No. 0
None 51 41 26 26
Fever 37 30 37 37
Rash 5 4 5 5
Rash-Fever 32 26 32 32
An effective means of inducing active immunity, therefore, would be
especially desirable under these conditions.
Measles vaccine has now been given to 125 patients with cystic fibrosis.
Incidence of reactions to vaccination, as summarized in Table 2, was
apparently somewhat less in this group as compared with that in the other
children we have discussed. The difference, however, is probably to be
attributed largely to the inclusion in the cystic fibrosis group of a num-
ber of initially immune children. Thus antibody determinations carried
out on the pre-vaccination sera of 61 of these children indicated that about
20%o were initially immune. Using this factor to correct the data for the
entire group it is evident, as shown in the last column of Table 2, that
the incidence of rash and fever approached that previously observed. Post-
vaccination antibody titers in a sampling of 48 of the patients with cystic
fibrosis who responded serologically to vaccination ranged from 1:8 to
1:512 (dilution of serum) or higher. These results suggest no impairment
of the antibody-forming mechanism in patients with this disease. Unusually
severe or abnormal reactions were not observed nor was the underlying ill-
ness affected in any way. It would seem, then, that individuals with this
serious and debilitating illness tolerate the vaccine well.
A group of children were studied by Dr. Gibbs and Dr. Rosenthal
with a special purpose in view: namely, to determine whether after
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vaccination abnormalities in the electroencephalogram might occur. Pre-
viously Gibbs and his co-workers had found in a series of over 600 cases
of natural measles accompanied by no clinical evidence of encephalitis
that 51 per cent exhibited abnormal slowing of the brain waves. It was
shown that these abnormal patterns were not due to fever per se. Gibbs
and Rosenthal have now completed electroencephalograms in 40 children
taken just before and 10 days after measles vaccination. Twenty-eight of the
subjects were considered to be susceptible on the basis of serological tests.
The reactions to the vaccine were entirely comparable to those I have al-
ready described. With a single exception no deviations from the pre-
vaccination electroencephalographic patterns were noted. The exceptional
child was suffering from a febrile upper respiratory tract infection at
the time the second electroencephalogram was made. It has been stated
by Gibbs that such infections may be accompanied by the type of transitory
slowing that was recorded in this case.
These essentially negative electroencephalographic findings following
vaccination led Gibbs and Rosenthal to conclude that fear of abnormalities
in the electroencephalogram similar to those induced by natural measles
can be excluded as a possible contra-indication to large scale use of the
vaccine.
Prophylactic Effect of Vaccination. We may now ask how effective this
vaccine has proved to be in the prevention of illness following exposure
to measles. So far as we are aware no case of the disease has as yet
developed in any of the approximately 500children thathave beenvaccinated.
Instances of known exposure, however, have not been numerous. Even
so, there is available sufficient evidence to show that protection conferred
by vaccination is of a high order. Thus, Krugman working in an in-
stitution for mental illness reported that none of 23 vaccinated children
developed measles after intimate and prolonged exposure. In the same
ward, 17 among 23 unvaccinated children came down with the disease
and, in an adjoining ward, 29 among 50 unvaccinated inmates acquired
measles. In Krugman's study the vaccine was administered about seven
weeks before exposure occurred. Of the 23 vaccinated children who sub-
sequently proved resistant on exposure, 18 children had exhibited the
usual clinical and serological responses to vaccination.
Complete protection has also been observed by Lepow, Haggerty, and
Schwachman among 35 vaccinated children considered to be susceptible
at the time of vaccinaticn. These children were exposed in the home to
siblings with measles. The interval between vaccination and exposure in
these family studies varied from 2 months to 16 months.
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That the measles attack rate ranges from 75 to 95 per cent following
exposure is known to everyone. Accordingly, these observations while
limited seem sufficient to justify the conclusion that the attenuated virus
vaccine prepared and administered in the manner I have described is
a highly efficient prophylactic during relatively short periods. Only with
the passage of time can the duration of protection be finally assessed.
Nevertheless, the persistence of neutralizing antibodies for at last 2/2
years as demonstrated in our first trial encourages us to believe that im-
munity may be durable, possibly as durable as that established by the natural
disease.
Trials with Other Vaccines. Recently a number of other workers have
carried out trials with living measles virus vaccines. Some of these
have appeared in the literature; others are still in progress. Certain of
the vaccines employed were prepared with our strain of chick-adapted
virus but subjected to different conditions of cultivation. Others such
as those tested by Smorodintsov in Leningrad consisted of entirely dif-
ferent strains. It is not my purpose to review these findings in detail.
In general it can be said that with chick-adapted virus the characteristics
of the clinical response have been broadly comparable to those I have
described. Certain differences, however, were noted. For example,
Schwarz and his co-workers isolated virus from the blood of one of
two vaccinated children and Smorodintsev described frequent viral re-
covery from blood and throat washings from his subjects. McCrumb in
Baltimore who studied a vaccine consisting of Edmonston chick-adapted
virus that had been propagated for a few passages in canine renal cells,
also encountered the agent more often in blood and throat washings.
Hoenkenga and his associates employing chick cell vaccine reported that
four poorly nourished children were sufficiently ill to be cared for in
hospital during short periods. Satisfactory antibody responses were ob-
tained by all these workers and several also reported a high level of
resistance as measured by exposure to measles.
FUTURE DEVELOPMENTS
In this paper, I have attempted to outline some of the salient features
of the history and present status of vaccination against measles. In
conclusion we may consider very briefly what the future of vaccination
may be. First it seems clear that the need for a simple, safe, and effective
method for promoting lasting immunity will ensure continuation of efforts
to perfect the vaccines now at hand. The need is emphasized merely by
citing the incidence of measles in a country like the United States where
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the annual reported attack rate outdistances that of any other notifiable
disease. For example, about 5/2 million cases were notified during the 10
year period from 1950 to 1959. The total incidence during this time is
conservatively estimated at about 22 million cases. One has only to
visualize the vast amount of discomfort hidden behind these figures as
well as the additional burdens placed upon parents and the loss of time for
all concerned, to be convinced that elimination of measles would be desirable.
When we add to such considerations the danger of serious and often
fatal complications such as encephalitis, the need for a good prophylactic
receives additional emphasis. To support this statement I may note that
in the United States reported deaths from measles during the 3 year
period from 1956 to 1959 totaled 1471, whereas deaths from poliomyelitis
were recorded as 1042. Measles exceeded poliomyelitis mortality by about
Y3 during this period. Because measles encephalitis is known to vary
with time and place, it is difficult to estimate accurately the incidence of
this most serious complication. However, on what appears to be a fair
assumption, encephalitis develops in about one out of 800 patients.
On this basis I have calculated that about 28,000 cases occurred in the
United States during the ten year period from 1950-1959.
In countries where nutrition and general sanitation are defective the
frequency of pneumonia and other complications may be much higher
with a corresponding increase in mortality. Under these conditions vac-
cination would seem to offer the only means of control that will be available
for some time to come.
Because of the occasional high fever following vaccination, the dis-
covery of means whereby such reactions may be eliminated will be a
major objective of future research. Already trials are in progress in
which modifying doses of gamma globulin are administered simultaneously
with chick attenuated virus vaccine. Initiated by McCrumb, these trials
are being extended by Krugman, Stokes, and Hilleman as well as others
in the United States. It is even now apparent that with this procedure post-
vaccinal reactions are considerably reduced and it has been shown that
antibody formation is not usually suppressed although it may be some-
what diminished. Little or nothing is yet known regarding the degree or
duration of the resistance that may be established by this technique.
If found effective, sero-vaccination of this sort might be adopted in certain
countries; but in others, it may be regarded as too complicated and
too expensive. Much effort will be exerted, I feel sure, to push further
the attenuation of the virus itself.
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Finally, trials of the presently available chick cell adapted vaccine should
be extended until they include sufficient numbers to give complete assur-
ance that it is never encephalitogenic. Once its innocuity in this respect
is demonstrated and its reactivity somewhat reduced we may predict that
Home's ancient dream will at last become a reality.
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